Exelixis

Reckitt Benckiser Group plc (Slough, UK). 2024 revenue ~£14.2B. Hygiene, health, nutrition brands: Dettol, Lysol, Mucinex, Nurofen, Enfamil. Surface chemistry, disinfection chemistry.

中国生物技术股份有限公司(北京)。国药集团旗下。中国最大的疫苗研发生产企业。新冠疫苗(Vero细胞): 新冠灭活疫苗年产能50亿剂。百白破、乙肝、脊灰疫苗。乙脑疫苗WHO预认证。

Imerys Graphite & Carbon (Bironico, Switzerland). Synthetic & natural graphite, carbon black. Battery anode materials (graphite). Thermal management: TIM. Conductive carbons for polymers.

The Estée Lauder Companies Inc. (New York, NY). 2024 revenue ~$15.6B. Prestige beauty chemistry: peptide complexes, hyaluronic acid, niacinamide, retinoids. Clinical skincare: Advanced Night Repair. 60K+ employees.

昭和電工株式会社(東京)電子ガス事業。半導体用高純度ガス: アルシン、ジボラン、シラン、三フッ化窒素(NF3)。世界シェアのNF3。合成石英(ADVANTAQ)。ガリウム(LED原料)。化学品総合メーカー。

中盐内蒙古化工股份有限公司(呼和浩特)。2024年营收约80亿。金属钠、氯酸钠、三聚氰胺。世界最大金属钠生产商。核级金属钠。氯碱化工。盐化工产业链龙头。

The DEL (DNA-encoded library) screen identified 14 validated hit compounds.

Affinity selection mass spectrometry screened 100,000 compounds in one day.

百利科技股份有限公司(岳阳)。2024年营收约40亿。石油化工催化剂: 催化裂化(FCC)催化剂、加氢催化剂。S-Zorb脱硫催化剂。炼油催化剂国产化。中石化核心供应商。

日油株式会社(東京)。旧日産化学工業。2024年売上約2000億円。農薬: グリホサート、クレンシン(Indaziflam)。電子材料: 半導体用CMPスラリー、フォトレジスト。医薬中間体。

Servier Laboratories (Suresnes, France). 2024 revenue ~€5.3B. Private pharma. Oncology: Lonsurf, Onureg. Cardiovascular: Coversyl, Corbilian. 22K employees. Non-profit foundation ownership.

Livent Corporation (Philadelphia, PA, now part of Arcadium Lithium). Lithium hydroxide, butyllithium, lithium metal. Battery-grade LiOH. LipoLite, LioVedx. Hydroxide process from β-spodumene.

The supramolecular hydrogel showed shear-thinning and self-healing behavior.

Henkel Adhesive Technologies (Düsseldorf). 2024 revenue ~€10.8B. #1 adhesives globally. Loctite (threadlockers, epoxy), Technomelt (hot melt), Aquence. Reactive & non-reactive adhesives for automotive, electronics, packaging.

The perovskite solar cell achieved 25.7% PCE with excellent moisture stability.

珠海联邦制药股份有限公司。2024年营收约150亿。半合成青霉素、头孢菌素。胰岛素: 重组人胰岛素、甘精胰岛素、门冬胰岛素。原料药+制剂一体化。抗生素产业链。

The CRISPR-Cas9 ribonucleoprotein delivery achieved 85% gene editing efficiency.

Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.

The market positioning here is well-thought-out.